Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.

about

Current Management of Childhood Acute Myeloid Leukemia.The Prevalence of fungal infections in children with hematologic malignancy in Ali-Asghar Children Hospital between 2005 and 2010.Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia.

P2860

Q30244036-CD1C1722-A93C-478C-8322-907CD2CA15F3 Q35470678-3F7013E3-B4AE-45B6-945F-74B28C33E589 Q49954137-F4B27943-393A-460A-8733-4CF6689152F4

P2860

Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q38196743

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Overview of therapy and strate ...... iatric acute myeloid leukemia.

@en

type

Item

label

Overview of therapy and strate ...... iatric acute myeloid leukemia.

@en

prefLabel

Overview of therapy and strate ...... iatric acute myeloid leukemia.

@en

P1476

Overview of therapy and strate ...... iatric acute myeloid leukemia.

@en

P2093

Kelly Faulk

http://www.w3.org/2001/XMLSchema#string

Lia Gore

http://www.w3.org/2001/XMLSchema#string

Todd Cooper

http://www.w3.org/2001/XMLSchema#string

P2860

Acute leukemias in children with Down syndrome

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

Structural and functional alterations of FLT3 in acute myeloid leukemia

Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Potent inhibition of DOT1L as treatment of MLL-fusion leukemia

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.

Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.

Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.

P2888

s40272-014-0067-3

P304

213-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40272-014-0067-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020098406

http://www.w3.org/2001/XMLSchema#string

P698

24639021

http://www.w3.org/2001/XMLSchema#string

Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.

about

P2860

P2860

Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698